Kawaguchi Chemical IndustryKawaguchi Chemical Industry Co., Ltd4361東証スタンダード化学FY ending Nov 2025, consolidated, J-GAAP
About 100% of Kawaguchi Chemical Industry's sales come from Pharmaceutical products, with Real estate leasing making up much of the rest.
Out of every ¥100 of sales, about ¥5 is left as operating profit.
Revenue changed +19.8% from the prior year, operating profit +370.8%.
Revenue +19.8% · profit +370.8%, calculated from disclosed figures.
Operating leverage: 18.75× (profit growth ÷ revenue growth)
FY ending Nov 2020 → FY ending Nov 2021
FY ending Nov 2020 → FY ending Nov 2021
For every ¥100 Kawaguchi Chemical Industry sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
Revenue by business segment, and the profit each one keeps.
※ Segment figures include inter-segment sales and do not sum to the company total
EDINET (FSA Japan)
有価証券報告書-第124期(2024/12/01-2025/11/30)
EDINET (FSA Japan)
有価証券報告書-第123期(2023/12/01-2024/11/30)
EDINET (FSA Japan)
有価証券報告書-第122期(2022/12/01-2023/11/30)
EDINET (FSA Japan)
有価証券報告書-第121期(2021/12/01-2022/11/30)
EDINET (FSA Japan)
有価証券報告書-第120期(令和2年12月1日-令和3年11月30日)
EDINET (FSA Japan)
有価証券報告書-第119期(令和1年12月1日-令和2年11月30日)
Extracted from XBRL: 49 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.